Tomsche David Scott 4
4 · IMMUCELL CORP /DE/ · Filed Apr 14, 2026
Research Summary
AI-generated summary of this filing
Immucell (ICCC) Director David Tomsche Receives 10,000-Share Award
What Happened
- Director David Scott Tomsche was granted a 10,000-share derivative award (reported as $0.00 per share) on April 16, 2025. The filing characterizes the grant as compensation for board services rather than an open-market purchase or sale.
Key Details
- Transaction date: 2025-04-16; Grant type: Award/derivative (Code A).
- Price reported: $0.00 per share; reported acquisition value: $0.
- Shares owned after transaction: not specified in the provided filing excerpt.
- Filing date: 2026-04-14 — this Form 4 was filed roughly one year after the transaction (late filing).
- Remark in filing: options were granted by the issuer to compensate directors for services on the issuer's board.
Context
- This was a director compensation grant (derivative award). The filing does not indicate exercises, immediate sales, vesting schedule, or tax-withholding actions. Grants for board service are routine compensation and do not by themselves indicate the director is buying or selling shares in the market. The late filing means the disclosure of the grant was delayed on public record.
Insider Transaction Report
Form 4
Tomsche David Scott
Director
Transactions
- Award
Non Qualified Stock Options (Right to buy)
2025-04-16+10,000→ 10,000 totalExercise: $5.49From: 2028-04-16Exp: 2030-04-16→ Common Stock (10,000 underlying)
Signature
/s/ Timothy C. Fiori Attorney-in-Fact|2026-04-14